Where NeoGenomics Stands With Analysts
Where NeoGenomics Stands With Analysts
NeoGenomics 在分析师中的立场
Ratings for NeoGenomics (NASDAQ:NEO) were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
在过去三个月中，有4位分析师提供了NeoGenomics（纳斯达克股票代码：NEO）的评级，显示了看涨和看跌的观点。
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
在下表中，您将找到他们最近的评级摘要，揭示了过去30天中情绪的变化，并将其与前几个月进行了比较。
Insights from analysts' 12-month price targets are revealed, presenting an average target of $20.5, a high estimate of $24.00, and a low estimate of $19.00. This current average reflects an increase of 2.5% from the previous average price target of $20.00.
分析师12个月目标股价的见解已经公布，平均目标股价为20.5美元，最高估计为24.00美元，低估值为19.00美元。目前的平均价格比之前的平均目标股价20.00美元增长了2.5％。
Breaking Down Analyst Ratings: A Detailed Examination
分解分析师评级：详细审查
In examining recent analyst actions, we gain...
在研究分析师最...
登录免费看全文
登录/注册